COMORBITÉS ET SÉCURITÉ DES PATIENTS = COMORBIDITIES AND PATIENTS' SECURITYDE HERT, Marc.Acta psychiatrica belgica. 2010, issn 0300-8967, p. 8, SUP1Article

Creativity and Psychopathology: A Systematic ReviewTHYS, Erik; SABBE, Bernard; DE HERT, Marc et al.Psychopathology. 2014, Vol 47, Num 3, pp 141-147, issn 0254-4962, 7 p.Article

Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature reviewDE HERT, Marc; DETRAUX, Johan; PEUSKENS, Joseph et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 605-624, issn 1474-0338, 20 p.Article

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 studyDE HERT, Marc; CORRELL, Christoph U; COHEN, Dan et al.Schizophrenia research. 2010, Vol 117, Num 1, pp 68-74, issn 0920-9964, 7 p.Article

Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review : Early career psychiatristsSIMON, Viktoria; VAN WINKEL, Ruud; DE HERT, Marc et al.The Journal of clinical psychiatry. 2009, Vol 70, Num 7, pp 1041-1050, issn 0160-6689, 10 p.Article

Risk factors for suicide in young people suffering from schizophrenia : a long-term follow-up studyDE HERT, Marc; MCKENZIE, Kwame; PEUSKENS, Jozef et al.Schizophrenia research. 2001, Vol 47, Num 2-3, pp 127-134, issn 0920-9964Article

Prevalence and correlates of seclusion and restraint use in children and adolescents: a systematic reviewDE HERT, Marc; DIRIX, Nele; DEMUNTER, Hella et al.European child & adolescent psychiatry. 2011, Vol 20, Num 5, pp 221-230, issn 1018-8827, 10 p.Article

A head-to-head comparison of sertindole and risperidone on metabolic parametersDE HERT, Marc; MITTOUX, Aurélia; YUAN HE et al.Schizophrenia research. 2010, Vol 123, Num 2-3, pp 276-277, issn 0920-9964, 2 p.Article

Metabolic control in patients with schizophrenia treated with amisulpride or olanzapinePEUSKENS, Joseph; DE HERT, Marc; MORTIMER, Ann et al.International clinical psychopharmacology. 2007, Vol 22, Num 3, pp 145-152, issn 0268-1315, 8 p.Article

Anticholinergic use in hospitalised schizophrenic patients in BelgiumDE HERT, Marc; WAMPERS, Martien; VAN WINKEL, Ruud et al.Psychiatry research. 2007, Vol 152, Num 2-3, pp 165-172, issn 0165-1781, 8 p.Article

The generic alternative in schizophrenia: Opportunity or threat?NUSS, Philippe; TAYLOR, David; DE HERT, Marc et al.CNS drugs. 2004, Vol 18, Num 12, pp 769-775, issn 1172-7047, 7 p.Article

DOUBLE DIAGNOSTIC DANS DES UNITES DE SOINS EN BELGIQUE: PREVALENCE ET OPTIONS THERAPEUTIQUES DISPONIBLES = DUAL DIAGNOSIS AMONG SCHIZOPHRENIC PATIENTS IN BELGIAN PSYCHIATRIC SERVICES: PREVALENCE AND AVAILABLE TREATMENT OPTIONSHERT MARC, De; KATARINA, Roos; BENOIT, Gillain et al.Acta psychiatrica belgica. 2010, Vol 110, Num 2, pp 43-50, issn 0300-8967, 8 p.Article

Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophreniaVANCAMPFORT, Davy; PROBST, Michel; STUBBS, Brendon et al.General hospital psychiatry. 2014, Vol 36, Num 2, pp 172-176, issn 0163-8343, 5 p.Article

Stereotypy in schizophreniaMORRENS, Manuel; HULSTIJN, Wouter; LEWI, Paul J et al.Schizophrenia research. 2006, Vol 84, Num 2-3, pp 397-404, issn 0920-9964, 8 p.Article

The relation between neurocognitive dysfunction and impaired insight in patients with schizophreniaSIMON, Viktoria; DE HERT, Marc; WAMPERS, Martien et al.European psychiatry. 2009, Vol 24, Num 4, pp 239-243, issn 0924-9338, 5 p.Article

Quality Assessment of Physical Activity Recommendations Within Clinical Practice Guidelines for the Prevention and Treatment of Cardio-metabolic Risk Factors in People With SchizophreniaVANCAMPFORT, Davy; SWEERS, Kim; PROBST, Michel et al.Community mental health journal. 2011, Vol 47, Num 6, pp 703-710, issn 0010-3853, 8 p.Article

Metabolic abnormalities associated with second generation antipsychotics : fact or fiction? Development of guidelines for screening and monitoringDE HERT, Marc; VAN EYCK, Dominique; DE NAYER, Andre et al.International clinical psychopharmacology. 2006, Vol 21, issn 0268-1315, S11-S15, SUP2Conference Paper

Metabolic syndrome and lung function in schizophrenia: A pilot studyVANCAMPFORT, Davy; PROBST, Michel; STUBBS, Brendon et al.Psychiatry research (Print). 2014, Vol 220, Num 1-2, pp 58-62, issn 0165-1781, 5 p.Article

Diabetes, physical activity participation and exercise capacity in patients with schizophreniaVANCAMPFORT, Davy; DE HERT, Marc; SWEERS, Kim et al.Psychiatry and clinical neurosciences (Carlton. Print). 2013, Vol 67, Num 6, pp 451-459, issn 1323-1316, 9 p.Article

Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients : One Century of Allgemeine Psychopathologie (1913 to 2013) by Karl JaspersMITCHELL, Alex J; VANCAMPFORT, Davy; DE HERDT, Amber et al.Schizophrenia bulletin. 2013, Vol 39, Num 2, pp 295-305, issn 0586-7614, 11 p.Article

Prediabetes in Patients Treated With Antipsychotic DrugsMANU, Peter; CORRELL, Christoph U; WINKEL, Ruud Van et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 4, pp 460-466, issn 0160-6689, 7 p.Article

Associations between sedentary behaviour and metabolic parameters in patients with schizophreniaVANCAMPFORT, Davy; PROBST, Michel; KNAPEN, Jan et al.Psychiatry research (Print). 2012, Vol 200, Num 2-3, pp 73-78, issn 0165-1781, 6 p.Article

Reliability, minimal detectable changes, practice effects and correlates of the 6-min walk test in patients with schizophreniaVANCAMPFORT, Davy; PROBST, Michel; SWEERS, Kim et al.Psychiatry research (Print). 2011, Vol 187, Num 1-2, pp 62-67, issn 0165-1781, 6 p.Article

Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: Critical Review and Future DirectionsDECOSTER, Jeroen; OS, Jim Van; MYIN-GERMEYS, Inez et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5015-5023, issn 1381-6128, 9 p.Article

Oral glucose tolerance tests in treated patients with schizophrenia. data to support an adaptation of the proposed guidelines for monitoring of patients on second generation antipsychotics?DE HERT, Marc; VAN EYCK, Dominique; HANSSENS, Linda et al.European psychiatry. 2006, Vol 21, Num 4, pp 224-226, issn 0924-9338, 3 p.Article